knowledge -WSS

knowledge

author：focus 2025-09-03 05:33:13 - browse：9

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： New documents shed light on MD Anderson Cancer Institute feud

hotspot

WSS

Community Health Systems hospitals under DOJ investigation

UnitedHealth sued over use of algorithm in Medicare Advantage plans

He's a Nobel laureate. Critics say he was misleading on Covid

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Medical school prerequisites are outdated

Weight loss drugs should be covered by insurers, AMA says

hotspot

knowledge

focus

Continuity nursing helped my family in our darkest PICU moments

White House drug czar issues call for 'recovery

New air purifier tech could be key to improving indoor air quality

UnitedHealth sued over use of algorithm in Medicare Advantage plans

In Memoriam: Notable people who died in 2023

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Hepatitis C has a cure — but many Americans still lack access to it

In utero gene editing: an explainer

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare’s new pay boost for primary care is angering specialists

explore

Antivenom research: Lessons from HIV applied in search for universal antidote

Cancer diagnosis changes perspective doctor, former hospital CEO

How state and local governments are sidelining science

The Harvard botanist who searched for psychedelics in the Amazon

NIH chief: government has fallen behind pharma on clinical trials

Medical school prerequisites are outdated

explore

Wikipedia

hotspot

entertainment